Key points are not available for this paper at this time.
IgA nephropathy is the most common primary glomerular disease and an important cause of uremia in China.The treatment of IgAN nephropathy is divided into two main categories: symptomatic supportive therapy; and the use of glucocorticoids in combination with or without other immunosuppressive agents to treat active, inflammatory lesions. Due to conflicting results from existing evidence-based medical evidence, the timing and effectiveness of IgAN immunosuppressive drugs remains controversial.
Zheng et al. (Mon,) studied this question.